COVID-19: Man dies in Imphal

Second patient to succumb to disease in city

July 30, 2020 09:51 am | Updated 09:51 am IST - IMPHAL

A girl buys surgical masks which are in high demand due to COVID-19 situation in Imphal. File photo

A girl buys surgical masks which are in high demand due to COVID-19 situation in Imphal. File photo

A 48-year-old man died at 2.30 a.m. on Thursday at Regional Institute of Medical Sciences (RIMS) here due to COVID-19 and other ailments, official sources said.

Watch | The immune system's response to a coronavirus attack

He is the second patient to succumb to the disease. A patient earlier died on Wednesday at the medical college. RIMS comes under the Union Ministry of Health and Family Welfare.

The man was a resident of Leimakhong in Imphal west district. C. Arunkumar, RIMS medical superintendent, said that he was admitted to the Nephrology Department of RIMS on June 8. He was suffering from chronic kidney disease, lung infection and other complications.

Download The Hindu’s multi-language e-book on essential COVID-19 information

Prof Arunmumar added that two resident doctors at RIMS also tested positive. So far, 22 doctors, nurses, paramedics and other employees at the institute have tested positive.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.